Genentech sues Biogen for debt over blockbuster MS drug

Published Date: 08 Mar 2023

Roche's Genentech Inc sued Biogen MA Inc in federal court in San Francisco, alleging that Biogen owed additional patent royalties from worldwide sales of its blockbuster multiple sclerosis and Crohn's disease drug, Tysabri.

Read Full News

Latest News

Durvalumab Tied to Extended Biliary Tract Cancer OS Benefit

Researchers examine 4-year outcomes of the phase 3 TOPAZ-1 study.

Low-Volume PEG Wins for Inpatient Bowel Cleansing

PEG 1 L beats ‘more-is-better’ pre-colonoscopy regimens, demonstrating more high-quality cleansing and greater tolerability than 2-L and 4-L formulations.

Why the Painless Abdominal Bloating in Middle-Age Man?

Admitted for pyelonephritis, but his diagnostic journey is just beginning

Beware Aspiration Risk in Chronic Pot Users

A cautionary tale of gastroparesis-related aspiration in NPO patient with no other risk factors

Unusual Confluence of Two Rare Syndromes Results in Peculiar Symptoms

Interpretation of an ultrasound exam made all the difference in creating a treatment plan

Common Meds Linked to Reduced Immunotherapy Benefit in Lung Cancer Trial

— Results highlight importance of careful evaluation of concurrent medications, researchers say

Todays Updates

Race, Geography Linked to Gaps in Prostate Cancer Care

A US government study finds racial disparities in care and a complicated relationship between distance to major cancer centers and patients’ treatment and outcomes.

Todays Updates

Race, Geography Linked to Gaps in Prostate Cancer Care

A US government study finds racial disparities in care and a complicated relationship between distance to major cancer centers and patients’ treatment and outcomes.

Latest News

Researchers examine 4-year outcomes of the phase 3 TOPAZ-1 study.

PEG 1 L beats ‘more-is-better’ pre-colonoscopy regimens, demonstrating more high-quality cleansing and greater tolerability than 2-L and 4-L formulations.

Admitted for pyelonephritis, but his diagnostic journey is just beginning

A cautionary tale of gastroparesis-related aspiration in NPO patient with no other risk factors

Interpretation of an ultrasound exam made all the difference in creating a treatment plan

— Results highlight importance of careful evaluation of concurrent medications, researchers say

News All Time

GLP-1s and Chronic Pancreatitis; Hypoglycemia After Bowel Prep; Lower GI Bleeding

News and commentary from the world of gastroenterology and hepatology

TIPS Was Tops for Refractory Hydrothorax in Cirrhosis

Majority of patients who received TIPS had a complete clinical response

Enhanced MRI Tops Ultrasound in Catching Early Liver Cancer

MRI approach also led to fewer false referrals

Multicancer Early Detection Test Fails to Reduce Cancers Detected at Late Stages

However, an increase in the detection of stage I/II cancers was observed

'A Grand Slam' in Pancreatic Cancer: Novel Pill Doubles Survival

RASolute 302 findings herald a new standard of care in previously treated patients

Albumin 5% Cut Mortality Rates in Sudden Liver Failure With Other Organ Failure

Treatment may be an effective bridge to transplantation for acute-on-chronic liver failure

Saroglitazar Boosts Response Rates in Primary Biliary Cholangitis

More than half of patients saw a biochemical response by 1 year with the novel oral agent

Targeted Combo Boosts PFS in BRAF-Mutant Metastatic Colorectal Cancer

Adding encorafenib and cetuximab to chemotherapy backbone also prolonged overall survival

Non-Operative Treatment for CRC May Include Observation After Complete Response

No difference in disease-free, overall survival compared with 3 years of maintenance therapy

Adding Immunotherapy-Based Combo Boosts PFS in Unresectable Liver Cancer

But is the higher incidence of grade 3/4 adverse events "a worthwhile price to pay?" expert asks

Large Study Links GLP-1s to Lower Risk of Multiple Cancers

Patients taking the drugs for obesity had a 41% lower risk of related cancers

Fart Frequency in Men vs Women; Organ Transplant in Celiacs; Engineered Gut Bacteria

News and commentary from the world of gastroenterology and hepatology

Study Warns on Sugary Drinks and Liver Cancer

However, no association between artificially sweetened drinks and liver cancer observed

Tolerability Concerns for GLP-1/Glucagon Agonist in Obesity, MASLD

Roughly one in five patients ditched survodutide due to adverse events

NICU Babies More Likely to Miss Rotavirus Vax

Study shows impact of guidelines' strict upper age limit and suggestion of delay until discharge

Gas-X Recall; MASLD and Alzheimer's Mortality; Counties Without a Gastroenterologist

News and commentary from the world of gastroenterology and hepatology

Recommended News For You

After targeted agents, a novel bispecific in EGFR-mutant lung cancer improves PFS.

Tennessee Pharmacies Sell Potent Ivermectin Pushed by Anti-Vaccine Doctor

tobacco use, the severity of their symptoms, and their desire to give up smoking among cancer survivors.

Team finds broken 'brake' on cancer mutation machine.

A single-cell analysis reveals a distinctive immunosuppressive tumor microenvironment in kidney cancer brain metastases.

Year in Review: Chronic Lymphocytic Leukemia

Eliminating the SRC-3 gene in immune cells causes an efficient, long-lasting anti-cancer response.

Recommended Articles For You

The Benefits and Side Effects of Vidaza Syndrome  

Understanding the Causes and Symptoms of Cavernous Sinus Thrombosis  

Hematopoietic Aging Load and Disease Susceptibility: Mechanisms, Clinical Implications, and Management 

Hepatocellular Carcinoma: Emerging Trends and Innovations in Diagnosis and Management 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Woman Loses 6-Year Battle With Mouth Tumor

2.

Lesser-known lobular breast cancer on the rise in U.S. women

3.

PSA Often Unchanged With Enzalutamide Progression

4.

Olaparib-Abiraterone in mCRPCs Selected by Biomarkers Outperforms Each Agent by Itself.

5.

To refute accusations that it failed to issue a cancer warning, Roundup's maker is asking lawmakers for assistance.

1.

Understanding Epidural Hematoma: Symptoms, Causes and Treatment 

2.

Intelligent Hematopoietic Cell-State Mapping: Transforming Diagnostic Precision and Clinical Decision-Making

3.

Cracking Oncology Drug Resistance: New Strategies to Overcome Challenges in Modern Cancer Therapy

4.

Unlocking the Secret to Accurate ANC Calculation with This Informative Blog Post

5.

Emicizumab in Infants with Severe Hemophilia A: HAVEN 7 Phase 3b Trial Insights

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII

2.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII

3.

Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients

4.

Efficient Management of First line ALK-rearranged NSCLC - Part VII

5.

The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot